EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Integration of Genome and Epigenetic Testing in the Diagnostic Evaluation of Developmental Delay: Differentiating Börjeson–Forssman–Lehmann (BFLS) and White–Kernohan (WHIKERS) Syndromes

Keri Ramsey, Supraja Prakash, Jennifer Kerkhof iD, Bekim Sadikovic, Susan White, Marcus Naymik, Jennifer Sloan, Anna Bonfitto, Newell Belnap iD, Meredith Sanchez-Castillo, Wayne Jepsen iD, Matthew Huentelman iD und 3 weitere

Genes · 04.08.2025 · 16 (8) · 933

DOI: 10.3390/genes16080933 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Genes, online erschienen am 04.08.2025. Verfasst von Keri Ramsey und 14 weiteren Autor:innen. Beteiligte Einrichtung: Center for Rare Childhood Disorders, Translational Genomics Research Institute (TGen), Phoenix, AZ 85004, USA. Hauptthemen laut MEDLINE: Developmental Disabilities, Intellectual Disability, Epigenesis, Genetic. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Translational Genomics Research Institute, TGen (Translational Genomics Research Institute, part, of City of Hope), the Royal Children’s Hospital Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

More than 1500 genes are associated with developmental delay and intellectual disability, with variants in many of these genes contributing to a shared phenotype. The discovery of variants of uncertain significance (VUS) found in these genes during genetic testing can lead to ambiguity and further delay in diagnosis and medical management. Phenotyping, additional genetic testing, and functional studies can all add valuable information to help reclassify these variants. Here we demonstrate the clinical utility of epigenetic signatures in prioritizing variants of uncertain significance in genes associated with developmental delay (DD) and intellectual disability (ID).

Methods

Genome sequencing was performed in a male with developmental delay. He was found to have VUSs in both PHF6 and DDB1 genes, linked with Börjeson–Forssman–Lehmann syndrome (BFLS) and White–Kernohan syndrome (WHIKERS), respectively. These two disorders share a similar phenotype but have distinct inheritance patterns and molecular pathogenic mechanisms. DNA methylation profiling (DNAm) of whole blood was performed using the clinically validated EpiSign assay.

Results

The proband’s methylation profile demonstrated a strong correlation with the BFLS methylation signature, supporting the PHF6 variant as a likely cause of his neurodevelopmental disorder.

Conclusions

Epigenetic testing for disorders with distinct methylation patterns can provide diagnostic utility when a patient presents with variants of uncertain significance in genes associated with developmental delay. Epigenetic signatures can also guide genetic counselling and family planning.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Developmental DisabilitiesIntellectual DisabilityEpigenesis, GeneticHumansMaleDNA MethylationGenetic TestingPhenotypeRepressor Proteins

Stichwörter der Autor:innen

BFLSDNA methylationEpigeneticsVUS clarificationWHIKERSgenome sequencingintellectual disability

Substanzen

PHF6 protein, humanRepressor Proteins

Autor:innen und Institutionen

  • Center for Rare Childhood Disorders, Translational Genomics Research Institute (TGen), Phoenix, AZ 85004, USA.
  • Phoenix Children's Hospital, Phoenix, AZ 85016, USA.
  • Verspeeten Clinical Genome Center, London Health Sciences Center, London, ON N6A 5W9, Canada.
  • Department of Pathology and Laboratory Medicine, Western University, London, ON N6A 5C1, Canada.
  • Victorian Clinical Genetics Services, Murdoch Children's Research Institute, Melbourne, VIC 3052, Australia.
  • Department of Paediatrics, Univerwsity of Melbourne, Melbourne, VIC 3010, Australia.

ORCID-Profile: Jennifer Kerkhof, Newell Belnap, Wayne Jepsen, Matthew Huentelman, Saunder Bernes, Vinodh Narayanan, Shagun Kaur

Förderung

  • Translational Genomics Research Institute
  • TGen (Translational Genomics Research Institute, part, of City of Hope)
  • the Royal Children’s Hospital Foundation
  • the Murdoch Children’s Research Institute
  • The Harbig Foundation
  • Paula Fox
  • The Andrew and Geraldine Buxton Foundation
  • The Pierce Armstrong Foundation

Zitieren

APA

Ramsey, K., Prakash, S., Kerkhof, J., Sadikovic, B., White, S., Naymik, M., Sloan, J., Bonfitto, A., Belnap, N., Sanchez-Castillo, M., Jepsen, W., Huentelman, M., Bernes, S., Narayanan, V., & Kaur, S. (2025). Integration of Genome and Epigenetic Testing in the Diagnostic Evaluation of Developmental Delay: Differentiating Börjeson–Forssman–Lehmann (BFLS) and White–Kernohan (WHIKERS) Syndromes. Genes, 16(8), 933. https://doi.org/10.3390/genes16080933

Vancouver

Ramsey K, Prakash S, Kerkhof J, Sadikovic B, White S, Naymik M, et al. Integration of Genome and Epigenetic Testing in the Diagnostic Evaluation of Developmental Delay: Differentiating Börjeson–Forssman–Lehmann (BFLS) and White–Kernohan (WHIKERS) Syndromes. Genes. 2025;16(8):933. doi:10.3390/genes16080933

BibTeX
@article{Ramsey2025,
  author = {Ramsey, Keri and Prakash, Supraja and Kerkhof, Jennifer and Sadikovic, Bekim and White, Susan and Naymik, Marcus and Sloan, Jennifer and Bonfitto, Anna and Belnap, Newell and Sanchez-Castillo, Meredith and Jepsen, Wayne and Huentelman, Matthew and Bernes, Saunder and Narayanan, Vinodh and Kaur, Shagun},
  title = {Integration of Genome and Epigenetic Testing in the Diagnostic Evaluation of Developmental Delay: Differentiating Börjeson–Forssman–Lehmann (BFLS) and White–Kernohan (WHIKERS) Syndromes},
  journal = {Genes},
  year = {2025},
  volume = {16},
  number = {8},
  pages = {933},
  doi = {10.3390/genes16080933}
}
Kostenlos starten →